Early erythropoiesis‐stimulating agents in preterm or low birth weight infants

This updated review (34 studies; n=3643) concludes that early administration of ESAs reduces the use of RBC transfusions, the volume of RBCs transfused, and donor exposure after study entry. Small reductions are likely to be of limited clinical importance.

Source:

Cochrane Database of Systematic Reviews